Christopher Bachran

1.5k total citations
48 papers, 1.2k citations indexed

About

Christopher Bachran is a scholar working on Molecular Biology, Immunology and Biotechnology. According to data from OpenAlex, Christopher Bachran has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 34 papers in Immunology and 10 papers in Biotechnology. Recurrent topics in Christopher Bachran's work include Toxin Mechanisms and Immunotoxins (32 papers), Natural product bioactivities and synthesis (11 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Christopher Bachran is often cited by papers focused on Toxin Mechanisms and Immunotoxins (32 papers), Natural product bioactivities and synthesis (11 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Christopher Bachran collaborates with scholars based in Germany, United States and United Kingdom. Christopher Bachran's co-authors include Hendrik Fuchs, Diana Bachran, Matthias F. Melzig, Mark Sutherland, Alexander Weng, Stephen H. Leppla, Iring Heisler, Lee Kim Swee, Rasem Fattah and P. Markus Deckert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Christopher Bachran

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Bachran Germany 21 820 528 236 129 127 48 1.2k
Karel Bezouška Czechia 26 1.3k 1.6× 657 1.2× 258 1.1× 177 1.4× 107 0.8× 81 2.1k
Doo‐Byoung Oh South Korea 27 1.6k 1.9× 362 0.7× 403 1.7× 132 1.0× 225 1.8× 92 2.1k
Yuan C. Lee United States 22 1.3k 1.6× 275 0.5× 221 0.9× 192 1.5× 49 0.4× 34 1.6k
Robert A. Spooner United Kingdom 22 794 1.0× 664 1.3× 527 2.2× 102 0.8× 108 0.9× 40 1.5k
Ryo Misaki Japan 23 943 1.1× 263 0.5× 379 1.6× 108 0.8× 134 1.1× 76 1.3k
Therese Buskas United States 18 1.9k 2.3× 494 0.9× 180 0.8× 403 3.1× 117 0.9× 22 2.2k
Noboru Tomiya United States 21 1.4k 1.7× 305 0.6× 262 1.1× 205 1.6× 77 0.6× 42 1.6k
Andrea Vera Spain 14 633 0.8× 311 0.6× 130 0.6× 67 0.5× 28 0.2× 32 1.1k
Yoshiho Nagata Japan 23 1.4k 1.7× 381 0.7× 368 1.6× 92 0.7× 490 3.9× 70 2.0k
Lai Yue Chan Australia 23 1.5k 1.9× 314 0.6× 253 1.1× 70 0.5× 369 2.9× 50 1.7k

Countries citing papers authored by Christopher Bachran

Since Specialization
Citations

This map shows the geographic impact of Christopher Bachran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Bachran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Bachran more than expected).

Fields of papers citing papers by Christopher Bachran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Bachran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Bachran. The network helps show where Christopher Bachran may publish in the future.

Co-authorship network of co-authors of Christopher Bachran

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Bachran. A scholar is included among the top collaborators of Christopher Bachran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Bachran. Christopher Bachran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bachran, Christopher, et al.. (2020). Sortase-A mediated chemoenzymatic lipidation of single-domain antibodies for cell membrane engineering. European Journal of Pharmaceutics and Biopharmaceutics. 153. 121–129. 8 indexed citations
2.
Bachran, Christopher, et al.. (2018). Sortaggable liposomes: Evaluation of reaction conditions for single-domain antibody conjugation by Sortase-A and targeting of CD11b+ myeloid cells. European Journal of Pharmaceutics and Biopharmaceutics. 133. 138–150. 18 indexed citations
3.
Schröder, Matthias, Christopher Bachran, Alex Rolfe, et al.. (2018). Genetic screen in myeloid cells identifies TNF-α autocrine secretion as a factor increasing MDSC suppressive activity via Nos2 up-regulation. Scientific Reports. 8(1). 13399–13399. 20 indexed citations
4.
Bachran, Christopher, et al.. (2018). Sortagging of liposomes with a murine CD11b-specific VHH increases in vitro and in vivo targeting specificity of myeloid cells. European Journal of Pharmaceutics and Biopharmaceutics. 134. 190–198. 11 indexed citations
5.
Schiller, Stefan, et al.. (2018). Pentaglycine lipid derivates – rp-HPLC analytics for bioorthogonal anchor molecules in targeted, multiple-composite liposomal drug delivery systems. International Journal of Pharmaceutics. 547(1-2). 602–610. 11 indexed citations
6.
Bachran, Christopher, Matthias Schröder, Juan J. Cragnolini, et al.. (2017). The activity of myeloid cell-specific VHH immunotoxins is target-, epitope-, subset- and organ dependent. Scientific Reports. 7(1). 17916–17916. 17 indexed citations
7.
Bachran, Christopher, P. K. Gupta, Clinton E. Leysath, et al.. (2014). Reductive Methylation and Mutation of an Anthrax Toxin Fusion Protein Modulates its Stability and Cytotoxicity. Scientific Reports. 4(1). 4754–4754. 11 indexed citations
8.
Bachran, Christopher, Clinton E. Leysath, Inka Sastalla, et al.. (2014). Cytolethal distending toxin B as a cell-killing component of tumor-targeted anthrax toxin fusion proteins. Cell Death and Disease. 5(1). e1003–e1003. 24 indexed citations
9.
Bachran, Christopher, et al.. (2014). Triterpenoid saponin augmention of saporin-based immunotoxin cytotoxicity for human leukaemia and lymphoma cells is partially immunospecific and target molecule dependent. Immunopharmacology and Immunotoxicology. 37(1). 42–55. 23 indexed citations
10.
Weng, Alexander, Mayank Thakur, Figen Beceren‐Braun, et al.. (2012). The toxin component of targeted anti‐tumor toxins determines their efficacy increase by saponins. Molecular Oncology. 6(3). 323–332. 39 indexed citations
11.
Fuchs, Hendrik, Diana Bachran, Alexander Weng, et al.. (2009). Saponins as Tool for Improved Targeted Tumor Therapies. Current Drug Targets. 10(2). 140–151. 64 indexed citations
12.
Fuchs, Hendrik & Christopher Bachran. (2009). Targeted Tumor Therapies at a Glance. Current Drug Targets. 10(2). 89–93. 32 indexed citations
13.
Weng, Alexander, Christopher Bachran, Hendrik Fuchs, et al.. (2009). Enhancement of saporin cytotoxicity by Gypsophila saponins—More than stimulation of endocytosis. Chemico-Biological Interactions. 181(3). 424–429. 18 indexed citations
14.
Bachran, Christopher, et al.. (2008). Chimeric toxins inhibit growth of primary oral squamous cell carcinoma cells. Cancer Biology & Therapy. 7(2). 237–242. 14 indexed citations
15.
Bachran, Christopher, et al.. (2008). Saponins in Tumor Therapy. Mini-Reviews in Medicinal Chemistry. 8(6). 575–584. 91 indexed citations
16.
Weng, Alexander, Christopher Bachran, Hendrik Fuchs, & Matthias F. Melzig. (2008). Soapwort saponins trigger clathrin-mediated endocytosis of saporin, a type I ribosome-inactivating protein. Chemico-Biological Interactions. 176(2-3). 204–211. 22 indexed citations
17.
Bachran, Christopher, Mark Sutherland, Diana Bachran, & Hendrik Fuchs. (2007). Patents on Immunotoxins and Chimeric Toxins for the Treatment of Cancer. Recent Patents on Drug Delivery & Formulation. 1(2). 105–115. 3 indexed citations
18.
Fuchs, Hendrik, Christopher Bachran, Tongyu Li, et al.. (2006). A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice. Journal of Controlled Release. 117(3). 342–350. 34 indexed citations
19.
Heisler, Iring, et al.. (2005). Combined application of saponin and chimeric toxins drastically enhances the targeted cytotoxicity on tumor cells. Journal of Controlled Release. 106(1-2). 123–137. 55 indexed citations
20.
Bachran, Christopher, Iring Heisler, Hendrik Fuchs, & Mark Sutherland. (2005). Influence of protein transduction domains on target-specific chimeric proteins. Biochemical and Biophysical Research Communications. 337(2). 602–609. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karel Bezouška Breakdown of academic impact, for papers by Doo‐Byoung Oh Breakdown of academic impact, for papers by Yuan C. Lee Breakdown of academic impact, for papers by Robert A. Spooner Breakdown of academic impact, for papers by Ryo Misaki Breakdown of academic impact, for papers by Therese Buskas Breakdown of academic impact, for papers by Noboru Tomiya Breakdown of academic impact, for papers by Andrea Vera Breakdown of academic impact, for papers by Yoshiho Nagata Breakdown of academic impact, for papers by Lai Yue Chan
Rankless by CCL
2026